# US 2003/0215859 A1 · DNA shuffling of monooxygenase genes for production of industrial chemicals

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0215859 A1
- Document ID: US20030215859A1
- Status: Published application
- Kind: A1
- Application number: 10/406,892
- Filed: 2003-04-04
- Published: 2003-11-20
- Earliest claimed: 1998-08-12
- Assignees: Maxygen, Inc.
- Inventors: Joseph A. Affholter; S. Christopher Davis; Sergey A. Selifonov
- Web page: https://patentgrep.com/patent/US20030215859A1

## CPC

- C12N 9/0073: {with NADH or NADPH as one donor, and incorporation of one atom of oxygen 1.14.13}
- C12N 9/0004: {Oxidoreductases (1.)}
- C12N 15/1027: {by DNA shuffling, e.g. RSR, STEP, RPR}
- C12N 15/1058: {Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms}
- C12N 15/1086: {Preparation or screening of expression libraries, e.g. reporter assays}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

This invention provides improved monoxygenases, dehydrogenases, and transferases that are useful for the biocatalytic synthesis of compounds such as α-hydroxycarboxylic acids, and aryl- and alkyl-hydroxy compounds. The polypeptides provided herein are improved in properties such as regioselectivity, enzymatic activity, stereospecificity, and the like. Methods for obtaining recombinant polynucleotides that encode these improved polypeptides are also provided, as are organisms that express the polypeptides and are thus useful for carrying out said biocatalytic syntheses. Also provided by the invention are methods for increasing said solvent resistance of organisms that are used in the synthetic methods.

## Claims

### Claim 1

A method for obtaining a polynucleotide that encodes an improved polypeptide comprising monooxygenase activity, wherein said improved polypeptide has at least one property improved over a naturally occurring monooxygenase polypeptide. said method comprising:
(a) creating a library of recombinant polynucleotides encoding a recombinant monooxygenase polypeptide; and
(b) screening said library to identify a recombinant polynucleotide that encodes an improved recombinant monooxygenase polypeptide that has at least one property improved over said naturally occurring polypeptide.

### Claim 2 (depends on 1)

The method according to claim 1, wherein said creating a library comprises:
shuffling a plurality of parental polynucleotides to produce one or more recombinant monooxygenase polynucleotide encoding said improved property.

### Claim 3 (depends on 1)

The method according to claim 1, wherein said monooxygenase activity is a member selected from alkene epoxidation, alkane hydroxylation, aromatic hydroxylation, N-dealkylation of alkylamines, S-dealkylation of reduced thio-organics, O-dealkylation of alkyl ethers, oxidation of aryloxy phenols, conversion of aldehydes to acids, dehydrogenation, decarbonylation, oxidative dehalogenation of haloaromatics and halohydrocarbons, Baeyer-Villiger monoxygenation, modification of cyclosporins, hydroxylation of mevastatin, oxygenation of sulfonylureas and combinations thereof.

### Claim 4 (depends on 2)

The method of claim 2, wherein at least one of said parental polynucleotides encode at least one monooxygenase activity.

### Claim 5 (depends on 2)

The method of claim 2, wherein said parental polynucleotides are homologous.

### Claim 6 (depends on 2)

The method of claim 2, wherein at least one of said parental polynucleotides does not encode a monooxygenase activity.

### Claim 7 (depends on 2)

The method of claim 2, wherein said parental monooxygenase polynucleotide encodes a polypeptide or polypeptide subsequence selected from a P450 oxygenase, a heme-dependent peroxidase, an iron sulfur monooxygenase, a quinone-dependent monooxygenase and combinations thereof.

### Claim 8 (depends on 2)

The method of claim 2, wherein a member selected from said parental polynucleotides, said one or more recombinant monooxygenase polynucleotide, said identified recombinant monooxygenase polynucleotide and combinations thereof is cloned into an expression vector.

### Claim 9 (depends on 1)

The method of claim 1, wherein said identified recombinant monooxygenase polynucleotide has an ability to catalyze an enzymatic reaction using a redox partner other than NADPH.

### Claim 10 (depends on 2)

The method of claim 2, further comprising:
creating a library of recombinant peroxide production activity polynucleotides encoding a recombinant hydrogen peroxide production activity;
screening said library to identify a recombinant polynucleotide that encodes an improved hydrogen peroxide production activity; and
co-expressing one or more of said identified hydrogen peroxide production activity polynucleotides and said identified recombinant monooxygenase polynucleotide in a cell.

### Claim 11 (depends on 2)

The method of claim 2, further comprising:
creating a library of recombinant epoxide hydrolase activity polynucleotides encoding a recombinant epoxide hydrolase activity;
screening said library to identify a recombinant polynucleotide that encodes an improved epoxide hydrolase activity; and
co-expressing one or more of said identified recombinant epoxide hydrolase activity polynucleotides and said identified recombinant monooxygenase polynucleotide in a cell.

### Claim 12 (depends on 2)

The method of claim 2, further comprising:
creating a library of recombinant dehydrogenase activity polynucleotides encoding a recombinant dehydrogenase activity;
screening said library to identify a recombinant polynucleotide that encodes an improved dehydrogenase activity; and
co-expressing one or more of said identified recombinant dehydrogenase activity polynucleotides and said identified recombinant monooxygenase polynucleotide in a cell.

### Claim 13 (depends on 1)

The method of claim 1, further comprising:
creating a library of recombinant transferase activity polynucleotides encoding a recombinant transferase activity;
screening said library to identify a recombinant polynucleotide that encodes an improved transferase activity; and
co-expressing one or more of said identified recombinant transferase activity polynucleotides and said identified recombinant monooxygenase polynucleotide in a cell.

### Claim 14 (depends on 13)

The method according to claim 13, wherein said transferase polynucleotide is a member selected from acyltransferases, glycosyltransferases, methyl transferases and combinations thereof.

### Claim 15 (depends on 2)

The method of claim 2, wherein said plurality of parental polynucleotides are shuffled to produce a library of recombinant polynucleotides comprising one or more library member polynucleotide encoding one or more monooxygenase activity, which library is selected for one or more monooxygenase activity selected from alkene epoxidation, alkane hydroxylation, aromatic hydroxylation, N-dealkylation of alkylanines, S-dealkylation of reduced thio-organics, O-dealkylation of alkyl ethers, oxidation of aryloxy phenols, conversion of aldehydes to acids, dehydrogenation, decarbonylation, oxidative dehalogenation of haloaromatics and halohydrocarbons, Baeyer-Villiger monoxygenation, modification of cyclosporins, hydroxylation of mevastatin, conversion of cholesterol to pregnenolone, and oxygenation of sulfonylureas.

### Claim 16 (depends on 1)

A library of recombinant polynucleotides comprising one or more monooxygenase activity made by said method of claim 1.

### Claim 17 (depends on 16)

The library of claim 16, wherein said library is a phage display library.

### Claim 18 (depends on 1)

An improved monooxygenase encoding nucleic acid prepared by the method according to claim 1.

### Claim 19 (depends on 2)

The method of claim 2, wherein said parental polynucleotides are shuffled in a plurality of cells, which cells are prokaryotes or eukaryotes.

### Claim 20 (depends on 2)

The method of claim 2, wherein said parental polynucleotides are shuffled in a plurality of cells, which cells are yeast, bacteria, or fungi.

### Claim 21 (depends on 2)

The method of claim 2, wherein said parental polynucleotides are shuffled in a plurality of cells; said method optionally further comprises one or more members selected from
(a) recombining DNA from said plurality of cells that display monooxygenase activity with a library of DNA fragments, at least one of which undergoes recombination with a segment in a cellular DNA present in said cells to produce recombined cells, or recombining DNA between said plurality of cells that display monooxygenase activity to produce cells with modified monooxygenase activity;
(b) recombining and screening said recombined or modified cells to produce further recombined cells that have evolved additionally modified monooxygenase activity; and
(c) repeating (a) or (b) until said further recombined cells. have acquired a desired monooxygenase activity.

### Claim 22 (depends on 2)

The method of claim 2, wherein said method further comprises:
(a) recombining at least one distinct or improved recombinant polynucleotide with a further monooxygenase activity polynucleotide, which further polynucleotide is identical to or different from one or more of said plurality of parental polynucleotides to produce a library of recombinant monooxygenase polynucleotides;
(b) screening said library to identify at least one further distinct or improved recombinant monooxygenase polynucleotide that exhibits a further improvement or distinct property compared to said plurality of parental polynucleotides; and, optionally,
(c) repeating (a) and (b) until said resulting further distinct or improved recombinant polynucleotide shows an additionally distinct or improved monooxygenase property.

### Claim 23 (depends on 2)

The method of claim 2, wherein said recombinant monooxygenase polynucleotide is present in one or more bacterial, yeast, or fungal cells and said method comprises:
pooling multiple separate monooxygenase polynucleotides;
screening said resulting pooled monooxygenase polynucleotides to identify an improved recombinant monooxygenase polynucleotides that exhibits an improved monooxygenase activity compared to a non-recombinant monooxygenase activity polynucleotide; and
cloning said improved recombinant nucleic acid.

### Claim 24 (depends on 23)

The method of claim 23, further comprising transducing said distinct or improved nucleic acid into a prokaryote or eukaryote.

### Claim 25 (depends on 2)

The method of claim 2, wherein said shuffling of a plurality of parental polynucleotides comprises family gene shuffling.

### Claim 26 (depends on 2)

The method of claim 2, wherein said shuffling of a plurality of parental nucleic acids comprises individual gene shuffling.

### Claim 27 (depends on 2)

A selected shuffled monooxygenase nucleic acid made by said method of claim 2.

### Claim 28

A DNA shuffling mixture, comprising: at least three homologous DNAs, each of which is derived from a polynucleotide encoding a member selected from a polypeptide encoding monooxygenase activity, a polypeptide fragment encoding monooxygenase activity and combinations thereof.

### Claim 29 (depends on 28)

The DNA shuffling mixture of claim 28, wherein said at least three homologous DNAs are present in cell culture or in vitro.

### Claim 30

A method for increasing monooxygenase activity in a cell, comprising: performing whole genome shuffling of a plurality of genomic polynucleotides in said cell and selecting for one or more monooxygenase activity.

### Claim 31 (depends on 30)

The method of claim 30, wherein said genomic nucleic acids are from a species or strain different from said cell.

### Claim 32 (depends on 30)

The method of claim 30, wherein said cell is of prokaryotic or eukaryotic origin.

### Claim 33 (depends on 30)

The method of claim 30, wherein said monooxygenase activity to be selected is alkene epoxidation, alkane hydroxylation, aromatic hydroxylation, N-dealkylation of alkylamines, S-dealkylation of reduced thio-organics, O-Dealkylation of alkyl ethers, oxidation of aryloxy phenols, conversion of aldehydes to acids, dehydrogenation, decarbonylation, oxidative dehalogenation of haloaromatics and halohydrocarbons, Baeyer-Villiger monoxygenation, modification of cyclosporins, hydroxylation of mevastatin, conversion of cholesterol to pregnenolone, oxygenation of sulfonylureas and combinations thereof.

### Claim 34

A method for obtaining a polynucleotide encoding an improved polypeptide acting on a substrate comprising a target group selected from an olefin. a terminal methyl group, a methylene group, an aryl groupland combinations thereof, wherein said improved polypeptide exhibits one or more improved properties compared to a naturally occurring polypeptide acting on said substrate, said method comprising:
creating a library of recombinant polynucleotides that encoding a monooxygenase polypeptide acting on said substrate; and
screening said library to identify a recombinant polynucleotide encoding an improved polypeptide that exhibits one or more improved properties compared to a naturally occurring monooxygenase polypeptide.

### Claim 35 (depends on 34)

The method according to claim 34, wherein said library of recombinant polynucleotides is created by recombining at least a first form and a second form of a nucleic acid, at least one form encoding said naturally occurring polypeptide or a fragment thereof, wherein said first form and said second form differ from each other in two or more nucleotides.

### Claim 36 (depends on 35)

The method according to claim 35, wherein said first and second forms of said nucleic acid are homologous.

### Claim 37 (depends on 35)

The method according to claim 35, wherein at least one of said first and second forms of said nucleic acid does not encode a polypeptide having monooxygenase activity.

### Claim 38 (depends on 34)

A polypeptide encoded by a polynucleotide according to claim 34.

### Claim 39 (depends on 38)

The polypeptide according to claim 38 wherein said polypeptide has an activity comprising, converting an olefin to an epoxide.

### Claim 40 (depends on 38)

The polypeptide according to claim 38, wherein said polypeptide has an activity comprising, converting said terminal methyl group to a hydroxymethyl group.

### Claim 41 (depends on 38)

The polypeptide according to claim 38, wherein said polypeptide has an activity comprising, converting a methylene group to a hydroxmethylene group.

### Claim 42 (depends on 38)

The polypeptide according to claim 38, wherein said polypeptide has an activity comprising, converting an aryl group to a hydroxyaryl group.

### Claim 43 (depends on 38)

The polypeptide according to claim 38, wherein said improved property is selected from:
improved regiospecificity of said acting on a substrate, wherein said substrate comprises at least two target groups;
enhanced production of a desired enantiomeric form of a reaction product;
enhanced expression of said polypeptide by a host cell that comprises said recombinant polynucleotide; and
enhanced stability of said polypeptide in said presence of an organic solvent.

### Claim 44 (depends on 38)

A method of oxidizing a substrate comprising a target group selected from an olefin, a terminal methyl group, a methylene group, an aryl group and combinations thereof, said method comprising contacting said substrate with a polypeptide according to claim 38

### Claim 45 (depends on 44)

The method according to claim 44, wherein said absolute configuration of a product of said monooxygenase is R, S, or a mixture thereof.

### Claim 46 (depends on 39)

A method for preparing an epoxide group, said method comprising contacting a substrate comprising a carbon-carbon double bond with a polypeptide according to claim 39.

### Claim 47 (depends on 40)

A method for preparing a hydroxymethyl group, said method comprising contacting a substrate comprising a terminal methyl group with a polypeptide according to claim 40.

### Claim 48 (depends on 41)

A method for preparing a hydroxymethylene group, said method comprising contacting a substrate comprising a methylene group with a polypeptide according to claim 41.

### Claim 49 (depends on 42)

A method for preparing a hydroxyaryl group, said method comprising contacting a substrate comprising an aryl group with a polypeptide according to claim 42.

### Claim 50

An organism comprising a recombinant monooxygenase polynucleotide encoding an improved polypeptide that catalyzes a reaction selected from epoxidation of an olefin, hydroxylation of a terminal methyl group, hydroxylation of a methylene group, hydroxylation of an aryl group and combinations thereof wherein said polypeptide exhibits one property improved relative to a corresponding property of a naturally occurring monooxygenase polypeptide.

### Claim 51 (depends on 50)

The organism according to claim 50, further comprising an improved transferase polypeptide that exhibits one or more improved properties improved relative to a corresponding property of a naturally occurring transferase polypeptide.

### Claim 52 (depends on 51)

The organism according to claim 51, wherein said transferase is selected from S-adenosylmethionine dependent O-methyltransferase, acyl-CoA transferase and combinations thereof.

### Claim 53 (depends on 50)

The organism according to claim 50, further comprising an improved ligase peptide that exhibits one or more properties improved relative to a corresponding property of a naturally occurring ligase polypeptide.

### Claim 54 (depends on 53)

The organism according to claim 53, wherein said ligase is an acyl CoA ligase.

### Claim 55 (depends on 50)

The organism according to claim 50, further comprising an improved racemase polypeptide that exhibits one or more properties improved relative to a corresponding property of a naturally occurring racemase polypeptide.

### Claim 56 (depends on 55)

The organism according to claim 55, wherein said racemase s mandelate racemase.

### Claim 57 (depends on 50)

The organism according to claim 50, further comprising a dehydrogenase polypeptide that exhibits one or more properties improved relative to a corresponding property in a naturally occurring dehydrogenase polypeptide.

### Claim 58 (depends on 57)

The organism according to claim 57, said organism dehydrogenating a hydroxyalkyl group of a substrate having the structure:
15
wherein
R11, R12, R13 and R14 are independently selected from H and OH and at least one of R111, R12, R13 and R14 is OH;
n and s are independently selected from the numbers 0 to 16; and
p and t are independently selected from 0 to 6, wherein at least one of p and t must be at least one and p+t≦6,
said hydroxyalkyl group being dehydrogenated to a member selected from a carboxylic acid, a ketone carbonyl and an aldehyde carbonyl.

### Claim 59 (depends on 50)

The organism according to claim 50, further comprising an improved solvent resistance polypeptide that confers upon said organism a resistance to an organic solvent that is improved relative to that conferred by a naturally occurring solvent resistance-conferring polypeptide.

### Claim 60 (depends on 59)

The organism according to claim 59, wherein said improved solvent resistance polypeptide imparts to the organism a resistance to one or more organic compounds selected from olefins, α-hydroxycarboxylic acids, diols, aldehydes, ketones, halogenated hydrocarbons, perfluorocarbons, esters, aryl compounds, carboxylic acids, alcohols, ethers and combinations thereof.

### Claim 61 (depends on 59)

The organism of claim 59, wherein said improved solvent resistance polypeptide imparts to the organism a resistance to said solvent, wherein the solvent is present in a medium at hypersaturating concentrations.

### Claim 62 (depends on 50)

The organism according to claim 50, wherein said organism firher comprises an epoxide hydrolase polypeptide that exhibits one or more properties improved relative to a corresponding property of a naturally occurring epoxide hydrolase polypeptide.

### Claim 63 (depends on 50)

The organism according to claim 50, wherein said microorganism further comprises an epoxide isomerase polypeptide that exhibits one or more properties improved relative to a corresponding property of a naturally occurring epoxide isomerase polypeptide.

### Claim 64 (depends on 50)

The organism of claim 50, wherein said organism further comprises two or more recombinant polynucleotides selected from the group consisting of an improved transferase polypeptide that exhibits one or more properties improved relative to a corresponding property of a naturally occurring transferase polypeptide;
an improved epoxide hydrolase peptide that exhibits one or more properties improved relative to a corresponding property of a naturally occurring epoxide hydrolase polypeptide;
an improved ligase peptide that exhibits one or more properties improved relative to a corresponding property of a naturally occurring ligase polypeptide;
an improved racemase polypeptide that exhibits one or more properties improved relative to a corresponding property of a naturally occurring racemase polypeptide;
an improved dehydrogenase polypeptide that exhibits one or more properties improved relative to a corresponding property of a naturally occurring dehydrogenase polypeptide;
an improved epoxide isomerase polypeptide that exhibits one or more properties improved relative to a corresponding property of a naturally occurring epoxide isomerase polypeptide; and
an improved solvent resistance polypeptide that confers upon said organism a resistance to an organic solvent that is improved relative to that conferred by a naturally occurring solvent resistance-conferring polypeptide.

### Claim 65 (depends on 50)

A method for preparing an epoxide group, said method comprising contacting a substrate comprising a carbon-carbon double bond with an organism according to claim 50, thereby forming said epoxide group.

### Claim 66 (depends on 65)

The method according to claim 65, wherein said substrate is selected from styrene, styrene substituted on the phenyl group, divinylbenzene, divinylbenzene substituted on the phenyl group, isoprene, butadiene, diallyl ether, allyl phenyl ether, allyl phenyl ether substituted on the phenyl group, allyl alkyl ether, allyl aralkyl ether, vinylcyclohexene, vinylnorbornene, and acrolein.

### Claim 67 (depends on 50)

A method for converting an olefin into a vicinal diol, said method comprising:
(a) contacting said olefin with an organism according to claim 50 to form an epoxide; and
(b) contacting said epoxide with an organism comprising an epoxide hydrolase polypeptide, thereby forming said vicinal diol.

### Claim 68 (depends on 67)

The method according to claim 67, wherein said epoxide hydrolase polypeptide exhibits one or more properties improved relative to corresponding properties of a naturally occurring epoxide hydrolase polypeptide.

### Claim 69 (depends on 67)

The method according to claim 67, wherein said polypeptide of (a) and said polypeptide of (b) are expressed in the same host cell.

### Claim 70 (depends on 67)

The method according to claim 67, further comprising,
(c) contacting said vicinal diol with an organism comprising a polypeptide selected from a ligase polypeptide and a transferase polypeptide, thereby forming a vicinal diol adduct.

### Claim 71 (depends on 70)

The method according to claim 70, wherein said polypeptide of (c) is a polypeptide exhibiting one or more properties improved over a corresponding property of an analogous naturally occurring polypeptide.

### Claim 72 (depends on 70)

The method according to claim 70, wherein said polypeptide of (a), said polypeptide of (b) and said polypeptide of (c) are expressed in the same host cell.

### Claim 73 (depends on 67)

The method according to claim 67, wherein said vicinal diol has the structure:
16
wherein
R1 is selected from aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclyl, substituted heterocyclyl, —NR2R3, —OR2, —CN, C(R4)NR2R3 and C(R4)OR2 groups,
R2 and R3 are members independently selected from H, alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclyl and substituted heterocyclyl groups;
R4 is selected from ═O and ═S, and n is a number between 0 and 10, inclusive.

### Claim 74 (depends on 73)

The method according to claim 73, wherein
R1 is selected from phenyl, substituted phenyl, pyridyl, substituted pyridyl —NR2R3, —OCR2, —CN, C(R4)NR2R3 and C(R4)OR2 groups,
R2 and R3 are members independently selected from H, alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclyl and substituted heterocyclyl groups; and
R4 is selected from ═O and ═S.

### Claim 75 (depends on 50)

A method for converting an olefin into an α-hydroxycarboxylic acid, said method comprising:
(a) contacting said olefin with an organism according to claim 50 to form an epoxide;
(b) contacting said epoxide with an organism comprising an epoxide hydrolase polypeptide to form a vicinal diol; and
(c) contacting said vicinal diol with an organism comprising a dehydrogenase polypeptide to form said α-hydroxycarboxylic acid.

### Claim 76 (depends on 75)

The method according to claim 75, wherein at least one of said hydrolase polypeptide and said dehydrogenase polypeptide exhibits at least one property improved relative to a corresponding property in an analogous naturally occurring polypeptide.

### Claim 77 (depends on 78)

The method according to claim 78, wherein said polypeptide of (a), of (b) and of (c) are expressed in the same host cell.

### Claim 78 (depends on 64)

A method for converting an olefin into an α-hydroxycarboxylic acid, said method comprising, contacting said olefin with an organism according to claim 64, wherein said two or more recombinant polynucleotides are an improved epoxide hydrolase and an improved dehydrogenase.

### Claim 79 (depends on 78)

The method according to claim 78, further comprising:
(d) contacting said α-hydroxycarboxylic acid with an organism comprising an improved polypeptide having an activity selected from ligase, transferase and combinations thereof, thereby forming a α-hydroxycarboxylic acid adduct.

### Claim 80 (depends on 79)

The method according to claim 79, wherein at least two of said polypeptide of (a), (b), (c), (d) are expressed in the same host cell.

### Claim 81 (depends on 79)

The method according to claim 79, wherein at least one of said polypeptide selected from ligase, transferase and combinations thereof is an improved polypeptide.

### Claim 82 (depends on 78)

The method according to claim 78, wherein said α-hydroxycarboxylic acid has the structure:
17
wherein
R1 is selected from aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclyl, substituted heterocyclyl, R2R3, —OR2, —CN, C(R4)NR2R3 and C(R4)OR2 groups,
R2 and R3 are members independently selected from H, alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclyl and substituted heterocyclyl groups;
R4 is selected from ═O and ═S, and
n is a number between 0 and 10, inclusive.

### Claim 83 (depends on 82)

The method according to claim 82 wherein
R1 is selected from phenyl, substituted phenyl, pyridyl, substituted pyridyl —NR2R3, —OR2, —CN, C(R4)NR2R3 and C(R4)OR2 groups,
R2 and R3 are members independently selected from H, alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclyl and substituted heterocyclyl groups; and
R4 is selected from ═O and ═S.

### Claim 84 (depends on 79)

The method according to claim 79, wherein said transferase activity is selected from glycosyl transferase activity and methyltransferase activity.

### Claim 85 (depends on 84)

The method according to claim 84, wherein said methyl transferase is a S-adenosylmethionine dependent O-methyltransferase.

### Claim 86 (depends on 79)

The method according to claim 79, wherein said α-hydroxycarboxylic acid adduct has the structure:
18
wherein
R1 is selected from aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclyl, substituted heterocyclyl, —NR2R3(R4)m, —OR2, —CN, C(R5)NR2R3 and C(R5)OR2 groups,
R2, R3 and R4 are members independently selected from said group consisting of H, alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclyl and substituted heterocyclyl groups;
R5 is selected from ═O and ═S;
R6 is selected from H, alkyl and substituted alkyl groups;
R7 is C(O)R8, wherein R8 is selected from H alkyl and substituted alkyl groups and R7 and R8 are not both H;
m is 0 or 1, such that when m is 1, an ammonium salt is provided; and
n is a number between 0 and 10, inclusive.

### Claim 87 (depends on 86)

The method according to claim 86 wherein
R1 is selected from phenyl, substituted phenyl, pyridyl, substituted pyridyl —NR2R3, —OR2, —CN, C(R5)NR2R3 and C(R5)OR2,groups
R2 and R3 are members independently selected from said group consisting of H, C1-C6 alkyl and allyl; and
R5 is ═O.

### Claim 88 (depends on 50)

A method for preparing a hydroxy group, said method comprising:
(a) contacting a substrate comprising a terminal methyl group with a microorganism according to claim 50, thereby forming a hydroxymethyl group.

### Claim 89 (depends on 88)

The method according to claim 88, wherein said substrate comprises an alkyl-terminal methyl group as a component of a substrate selected from arylalkyl groups, substituted arylalkyl groups, heteroarylalkyl groups, and substituted heteroarylalkyl groups.

### Claim 90 (depends on 88)

The method according to claim 88, wherein said substrate has the structure
19
wherein,
each of said n R groups is a member selected from the group consisting of H, alkyl groups and substituted alkyl groups;
m is a number from 0 to 10, inclusive; and
n is a number from 0 to 5, inclusive.

### Claim 91 (depends on 90)

The method according to claim 90, wherein said substrate comprises benzene substituted with a member selected from the group of straight-chain alkyl groups branched-chain alkyl groups and combinations thereof.

### Claim 92 (depends on 91)

The method according to claim 91, wherein said substrate comprises benzene substituted with a member selected from C1-C6 straight-chain, C1-C6 branched-chain alkyl and combinations thereof.

### Claim 93 (depends on 92)

The method according to claim 92, wherein said alkyl group is selected from ethyl, n-propyl, i-propyl, t-butyl and combinations thereof.

### Claim 94 (depends on 92)

The method according to claim 92, wherein said substrate is
20
wherein n is a number between 0 and 9, inclusive.

### Claim 95 (depends on 92)

The method according to claim 92, wherein said substrate has the structure:
21
wherein n is a number between 1 and 6, inclusive.

### Claim 96 (depends on 88)

The method according to claim 88, wherein said hydroxy group is a component of a member selected from benzyl alcohol, substituted benzyl alcohol, 2-phenylethanol, substituted 2-phenylethanol, 3-phenylpropanol and substituted 3-phenylpropanol.

### Claim 97 (depends on 88)

The method according to claim 88, further comprising:
(b) contacting said hydroxymethyl group with an organism comprising an acyltransferase, thereby forming an acylated hydroxy adduct.

### Claim 98 (depends on 97)

The method according to claim 97, wherein said acyltransferase exhibits one or more properties improved relative to a corresponding property of a naturally occurring acyltransferase.

### Claim 99 (depends on 97)

The method according to claim 97, wherein said polypeptide of (a) and said polypeptide of (b) are expressed by the same host cell.

### Claim 100 (depends on 88)

The method according to claim 88, further comprising:
(b) contacting said hydroxymethyl group with a microorganism comprising an improved glycosyltransferase, thereby forming a glycosylated hydroxy adduct.

### Claim at position 101 (depends on 100)

101 The method according to claim 100, wherein said glycosyltransferase exhibits one or more properties improved relative to a corresponding property of a naturally occurring glycosyltransferase.

### Claim 102 (depends on 100)

The method according to claim 100, wherein said polypeptide of (a) and said polypeptide of (b) are expressed by the same host cell.

### Claim 103 (depends on 88)

The method according to claim 88, further comprising:
(b) contacting said hydroxy group with a microorganism comprising a dehydrogenase, thereby forming a carboxylic acid.

### Claim 104 (depends on 103)

The method according to claim 103, wherein said dehydrogenase exhibits one or more properties improved relative to a corresponding property of a naturally occurring dehydrogenase.

### Claim 105 (depends on 103)

The method according to claim 103, wherein said polypeptide of (a) and said polypeptide of (b) are expressed by the same host cell.

### Claim 106 (depends on 110)

The method according to claim 110, further comprising, contacting said carboxylic acid with a microorganism comprising an improved transferase, thereby forming a carboxylic acid ester.

### Claim 107 (depends on 50)

A method for preparing a hydroxymethylene group, said method comprising contacting a substrate comprising a methylene group with a microorganism according to claim 50.

### Claim 108 (depends on 107)

The method according to claim 107, wherein said substrate comprises a member selected from 3,4-dihydrocoumarin and 3,4-dihydrocoumarin residues.

### Claim 109 (depends on 107)

The method according to claim 107, wherein said substrate is 3,4-dihydrocoumarin and said polypeptide converts said substrate to 4-hydroxy-,4-dihydrocoumarin.

### Claim 110 (depends on 50)

A method for preparing a hydroxyaryl group, said method comprising:
(a) contacting a substrate comprising an aryl group with a microorganism according to claim 50.

### Claim 111 (depends on 110)

The method according to claim 110, wherein said substrate comprises a group selected from aryl groups, substituted aryl groups, heteroaryl groups and substituted heteroaryl groups.

### Claim 112 (depends on 110)

The method according to claim 110, further comprising:
(b) contacting said hydroxyaryl group with an organism comprising an acyltransferase, thereby forming an acylated hydroxyaryl adduct.

### Claim 113 (depends on 112)

The method according to claim 112, wherein said acyltransferase exhibits one or more properties improved relative to a corresponding property of a naturally occurring acyltransferase.

### Claim 114 (depends on 112)

The method according to claim 112, wherein said polypeptide of (a) and said polypeptide of (b) are expressed by the same host cell.

### Claim 115 (depends on 112)

The method according to claim 112, further comprising:
(b) contacting said hydroxyaryl group with a microorganism comprising a glycosyltransferase, thereby forming a glycosylated hydroxyaryl adduct.

### Claim at position 116 (depends on 115)

116 The method according to claim 115, wherein said glycosyltransferase exhibits one or more properties improved relative to a corresponding property of a naturally occurring glycosyltransferase.

### Claim 117 (depends on 115)

The method according to claim 115, wherein said polypeptide of (a) and said polypeptide of (b) are expressed by the same host cell.

### Claim 118

A screening process comprising:
(a) introducing the library of recombinant polynucleotides into a population of test microorganisms such that the recombinant polynucleotides are expressed;
(b) placing the organisms in a medium comprising at least one substrate; and
(c) and identifying those organisms exhibiting an improved propertv compared to microorganisms without the recombinant polynucleotide.

### Claim 119

A bioreactor comprising:
(a) an improved monooxygenase polypeptide;
(b) a redox partner;
(c) oxygen;
(d) an oxidizable substrate.

### Claim 120 (depends on 119)

The bioreactor according to claim 119, wherein said polypeptide is immobilized.

### Claim 121 (depends on 119)

The bioreactor according to claim 119, wherein said polypeptide is a chimeric polypeptide.

### Claim 122 (depends on 119)

The bioreactor according to claim 119, wherein said polypeptide is a P-450 polypeptide.

### Claim 123 (depends on 122)

The bioreactor according to claim 122, wherein said P-450 is a peroxide-stable P-450.

### Claim 124

A kit comprising:
(a) at least one improved monooxygenase polypeptide; and
(b) directions for using said polypeptide to carry out a chemical reaction.

### Claim 125 (depends on 124)

The kit according to claim 124, wherein said at least one improved monooxygenase polypeptide is a constituent of a library of improved polypeptides.

### Claim 126

A recombinant P450 polypeptide comprising a backbone domain and an active site domain, wherein at least one of said domains comprises at least two contiguous amino acids that are not contiguous in a naturally occurring P450 enzyme.

### Claim 127 (depends on 126)

The recombinant P450 polypeptide according to claim 126, wherein the junction between the active site domain and the backbone domain is at a location selected from an end of the I helix and within the G-H loop.

### Claim 128 (depends on 126)

The recombinant P450 polypeptide according to claim 126, wherein the F and G helices are transferred into the backbone P450.

### Claim 129 (depends on 126)

A polynucleotide that encodes a recombinant P450 polypeptide according to claim 126.

### Claim 130

A method of obtaining a polynucleotide that encodes a recombinant P450 polypeptide comprising a backbone domain and an active site domain, said method comprising:
(a) recombining at least first and second forms of a nucleic acid that encodes a P450 active site domain, wherein the first and second forms differ from each other in two or more nucleotides to produce a library of recombinant active site domain encoding polynucleotides; and
(b) linking the recombinant active site domain-encoding polynucleotide to a backbone-encoding polynucleotide so that the active site-encoding domain and the backbone-encoding domain are in-frame.

### Claim 131 (depends on 130)

The method according to claim 130, wherein said backbone is derived from P450BMP.

### Claim 132 (depends on 130)

The method according to claim 130, wherein said backbone domain and said recombinant active-site domain are joined at a member selected from an end of the I helix and within the G-H loop.

### Claim 133 (depends on 130)

The method according to claim 130, wherein the F and G helices are transferred into the backbone P450.

### Claim 134

A method of obtaining a polynucleotide that encodes a recombinant P450 polypeptide comprising a backbone domain and an active site domain, said method comprising:
(a) recombining at least first and second forms of a nucleic acid that encodes a P450 backbone domain, wherein the first and second forms differ from each other in two or more nucleotides to produce a library of recombinant backbone domain encoding polynucleotides; and
(b) linking the recombinant backbone domain-encoding polynucleotide to a active site-encoding polynucleotide so that the backbone-encoding domain and the active site-encoding domain are in-frame.

### Claim 135 (depends on 134)

The method according to claim 134, wherein said backbone is derived from P450BMP.

### Claim 136 (depends on 134)

The method according to claim 134, wherein said backbone domain and said recombinant active-site domain are joined at a member selected from an end of the I helix and within the G-H loop.

### Claim 137 (depends on 134)

The method according to claim 134, wherein the F and G helices are transferred into the backbone P450.

### Claim 138

A method of obtaining a polynucleotide that encodes a recombinant P450 polypeptide comprising a backbone domain and an active site domain, said method comprising:
(a) recombining at least first and second forms of a nucleic acid that encodes a P450 active site domain, wherein the first and second forms differ from each other in two or more nucleotides to produce a library of recombinant active site domain encoding polynucleotides;
(b) recombining at least first and second forms of a nucleic acid that encodes a P450 backbone domain, wherein the first and second forms differ from each other in two or more nucleotides to produce a library of recombinant backbone domain encoding polynucleotides; and
(c) linking the recombinant active site domain-encoding polynucleotide to the recombinant backbone-encoding polynucleotide so that the recombinant active site-encoding domain and the recombinant backbone-encoding domain are in-frame.

### Claim 139 (depends on 138)

The method according to claim 138, wherein said backbone is derived from P450BMP.

### Claim 140 (depends on 138)

The method according to claim 138, wherein said backbone domain and said recombinant active-site domain are joined at a member selected from an end of the I helix and within the G-H loop.

### Claim 141 (depends on 138)

The method according to claim 138, wherein the F and G helices are transferred into the backbone P450.
